Brought to you by:
New era beckons: Vascular Specialist moves in-house as new chapter opens for SVS official newspaper
Malachi Sheahan III, MD, has been at the helm of Vascular Specialist for more than seven years. In that time, it is fair to say the newspaper—the official voice of the Society for Vascular Surgery (SVS)—has evolved. About a year…
Chronic venous insufficiency: Appeal over ‘not-approvable’ VenoValve fails
enVVeno Medical has announced that it received an “unfavorable” decision from the Food & Drug Administration (FDA) in response to its supervisory appeal of the “not-approvable” letter it received on Aug. 19 in response to its premarket approval (PMA) application…
Randomized data ‘debunks’ widely used negative pressure wound therapy
“How did an ineffective and costly intervention become routine care in the NHS [UK National Health Service]?” Ian Chetter, MBChB, chair of surgery at Hull York Medical School, University of Hull in Hull, England, posed at the 39th European Society…
Celebrity-prompted awareness in vascular surgery
The vascular surgery field received a rare moment in the public spotlight recently as President Donald J. Trump was diagnosed with chronic venous insufficiency (CVI). The White House press secretary and appointed physician to the president even made statements on…
In wake of President Trump’s chronic venous insufficiency diagnosis, SVS steps up to educate public
News that U.S. President Donald J. Trump has a vascular condition may have simultaneously revealed that a substantial seven-figure vascular surgery branding campaign was starting to yield tangible results, and provided a singular opportunity to platform the specialty as the…
Vascular surgery history: Putting specialty on the map in a broader sense
The people, discoveries, innovations and events that brought the vascular surgery profession to where it is today formed the bedrock of the subject matter for this year’s John Homans Lecture—“Who put the vascular in vascular surgery?”—at the 2025 Vascular Annual…
Two-year data show continued clinical improvement with VenoValve
Implantation of the VenoValve (enVVeno Medical) continues to promote stabilization of symptoms in patients with deep venous reflux at two-year follow-up. This is the headline finding of data shared yesterday during Plenary Session 6 at VAM 2025. In the abstract…
VenoValve: Analysis finds similar improvement among both primary and thrombotic deep venous reflux patients
A new subanalysis of the SAVVE (Surgical antireflux venous valve endoprosthesis) trial found that there was no difference in the level of improvement in clinical outcomes and quality-of-life measures between patients who have either primary or thrombotic deep venous reflux.…
New analysis details learning curve effect behind ‘significant improvement’ in performance of PE mechanical thrombectomy over time
A multisite hospital system analysis of the safety and procedural learning curve behind the performance of percutaneous mechanical thrombectomy for pulmonary embolism (PE) shows significant reductions in both fluoroscopy and procedure times alongside contrast volume over time. The data, the…
One-year SAVVE trial results are ‘most encouraging data ever produced for a bioprosthetic vein valve’
The one-year data from the SAVVE trial represent the “most encouraging clinical data that have ever been produced for a bioprosthetic deep vein valve” in more than half a century of attempts at developing such a device, according to one…